2023 Combo Save the Dates2

BioHealth Innovation, Inc. (BHI) is proud to announce that US Pharmacopeia (USP) will be hosting the 9th Annual BioHealth Capital Region Forum for the second year in a row on September 19th and 20th, 2023. In addition to this flagship event, USP will also host the 8th Annual BioHealth Capital Region Crab Trap Competition on September 20th and the 6th Annual BioHealth Capital Region Investment Conference on September 21st.

"We are looking forward to once again hosting the BioHealth Capital Region Forum. As an integral part of this dynamic region, USP is deeply committed to fostering innovation and collaboration across the BioHealth space. USP eagerly anticipates bringing together leading minds and stakeholders to advance our shared vision for the future." said Anthony Lakavage, J.D., SVP of Global External Affairs at USP.

 

The BioHealth Capital Region (BHCR) stands as one of the largest and most vibrant biohubs in the United States, boasting a unique and unparalleled concentration of assets in the life sciences and biotechnology sectors. Situated within the dynamic corridor that encompasses Washington, D.C., Maryland, and Virginia, the BHCR is home to key federal agencies such as the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), which contribute to the region's stature as a center of cutting-edge research and regulatory expertise. In addition to these government entities, the BHCR is also home to world-class BioHealth companies that drive innovation and development in the field. Complementing this ecosystem is the presence of top-tier educational institutions that foster a highly skilled workforce and provide research and collaboration opportunities. Collectively, these one-of-a-kind assets establish the BioHealth Capital Region as a premier destination for biotech innovation, collaboration, and growth.

"We are thrilled to embark on another year of fostering innovation and collaboration within the biohealth industry. The upcoming BioHealth Capital Region Forum, the Investment Conference, and the Crab Trap competition represent exciting opportunities to engage with industry leaders, showcase groundbreaking ideas, and foster valuable partnerships. I want to extend my heartfelt thanks to The United States Pharmacopeial Convention (USP) for graciously hosting these events for the second year in a row in 2023. Their dedication to advancing global health and their support for this region is commendable. Together, we will continue to drive forward the vision of a healthier and brighter future for all." — Rich Bendis, President, and CEO, BioHealth Innovation 

BHI is a public-private nonprofit organization focused on accelerating biohealth commercialization in the BioHealth Capital Region (Maryland, DC, and Virginia). BHI's team of experts facilitates technology commercialization, raises the industry's profile, increases access to capital, and expands the talent pool with commercial experience. BHI manages wet lab space, co-hosts annual events, and provides support to early-stage companies and international firms.

USP, an independent, scientific nonprofit with over 200 years of history, builds trust in the world's medicines, supplements, and foods through rigorous science and quality standards. USP envisions a world with access to high-quality, safe medicines, and is committed to improving global health and fostering a diverse and inclusive culture.

The 9th Annual BioHealth Capital Region Forum is a unique opportunity for stakeholders to engage in discussions on advancing the biohealth industry. USP is excited to host the Crab Trap Competition, where startups pitch to experienced investors and experts. The series of events culminates with the Investment Conference, fostering investment opportunities and partnerships.

Registration for both the Forum and Investment Conference will be coming soon, and applications to compete in the Crab Trap competition will also be available soon. Join us for these exciting events, and together, let's continue to build a brighter future for the biohealth industry and contribute to a healthier tomorrow.